Imaging cellular metabolic heterogeneity in cancer

Melissa C. Skala, Alex J. Walsh, Amy T. Shah, Joseph T. Sharick, Tiffany M. Heaster, Rebecca S. Cook, Carlos L. Arteaga, Melinda E. Sanders, Ingrid Meszoely

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Optical metabolic imaging (OMI) quantifies the fluorescence intensities and lifetimes of NADH and FAD using two-photon microscopy. OMI allows for cells to be monitored within tumors, to design effective cancer therapies and personalize cancer treatment.

Original languageEnglish (US)
Title of host publicationCancer Imaging and Therapy, CANCER 2016
PublisherOptica Publishing Group (formerly OSA)
ISBN (Print)9781943580101
DOIs
StatePublished - 2016
EventCancer Imaging and Therapy, CANCER 2016 - Fort Lauderdale, United States
Duration: Apr 25 2016Apr 28 2016

Publication series

NameOptics InfoBase Conference Papers
ISSN (Electronic)2162-2701

Conference

ConferenceCancer Imaging and Therapy, CANCER 2016
Country/TerritoryUnited States
CityFort Lauderdale
Period4/25/164/28/16

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Mechanics of Materials

Fingerprint

Dive into the research topics of 'Imaging cellular metabolic heterogeneity in cancer'. Together they form a unique fingerprint.

Cite this